Hydrogenology
Source-linked study record

Inhalation of hydrogen gas ameliorates glyoxylate-induced calcium oxalate deposition and renal oxidative stress in mice

Peng Z, Chen W, Wang L, Ye Z, Gao S, Sun X, Guo Z. · International Journal of Clinical and Experimental Pathology. 2015;8(3):2680-2689.

PreclinicalInhaled H₂Published 2015Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

Male C57BL/6 mice in a five-day glyoxylate-induced renal calcium-oxalate deposition model.

Intervention and dose

A 67% H₂/33% O₂ mixture was inhaled in a closed box for 30 minutes daily for seven days, starting two days before the five-day glyoxylate course. · The total mixture entered the chamber at 200 mL/min. Directly from the reported 67%/33% composition, H₂ flow was 134 mL/min and O₂ flow was 66 mL/min. The control mixture was 67% N₂/33% O₂ at the same total flow.

Duration

Thirty minutes daily for seven consecutive days; glyoxylate 100 mg/kg/day was given intraperitoneally on days 3-7.

Reported result

Brown's-gas pretreatment reduced renal crystal deposition, calcium, KIM-1, apoptosis and several oxidative/inflammatory markers and increased antioxidant measures and IL-10. H₂/O₂ alone did not change urinary calcium/phosphate ratios, renal calcium or KIM-1; renal MPO did not differ significantly.

Main limitation

Small n=6 groups, prophylactic treatment beginning before injury, short chemical-crystallization model, many surrogate endpoints and no comparison with established stone-prevention treatments. Chinese national, Shanghai and hospital grants were reported; authors disclosed no conflicts.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

Randomized four-group controlled mouse pretreatment experiment

Research topic

Kidney and urinary health

Administration form

Inhaled H₂

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Male C57BL/6 mice in a five-day glyoxylate-induced renal calcium-oxalate deposition model.

Sample

24 mice randomized to four groups of n=6: control gas, Brown's gas, glyoxylate plus control gas, or glyoxylate plus Brown's gas.

Duration

Thirty minutes daily for seven consecutive days; glyoxylate 100 mg/kg/day was given intraperitoneally on days 3-7.

Intervention

A 67% H₂/33% O₂ mixture was inhaled in a closed box for 30 minutes daily for seven days, starting two days before the five-day glyoxylate course.

Hydrogen form

Brown's gas / oxyhydrogen generated from water: approximately 66.7% H₂ and 33.3% O₂ in the source's 2:1 H₂:O₂ proportions.

Dose or H₂ specification

The total mixture entered the chamber at 200 mL/min. Directly from the reported 67%/33% composition, H₂ flow was 134 mL/min and O₂ flow was 66 mL/min. The control mixture was 67% N₂/33% O₂ at the same total flow.

H₂ flow

134 mL/min.

O₂ delivered with H₂

66 mL/min.

Comparator

Matching 67% N₂/33% O₂ control gas with and without glyoxylate, plus Brown's gas without glyoxylate.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Urinary minerals, renal calcium deposition, serum KIM-1, TUNEL apoptosis, MDA, 8-OHdG, SOD, GSH, catalase, MPO, OPN, CD44, MCP-1 and IL-10.

Reported result

Brown's-gas pretreatment reduced renal crystal deposition, calcium, KIM-1, apoptosis and several oxidative/inflammatory markers and increased antioxidant measures and IL-10. H₂/O₂ alone did not change urinary calcium/phosphate ratios, renal calcium or KIM-1; renal MPO did not differ significantly.

Extraction completeness

The complete free PMC article was checked for randomization, exact gas generator/composition, total flow, directly calculated H₂/O₂ flows, dosing schedule, positive and null outcomes, funding and conflict declaration.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Small n=6 groups, prophylactic treatment beginning before injury, short chemical-crystallization model, many surrogate endpoints and no comparison with established stone-prevention treatments. Chinese national, Shanghai and hospital grants were reported; authors disclosed no conflicts.

Applies directly to

Glyoxylate-induced calcium-oxalate deposition in male mice; it does not establish kidney-stone prevention or treatment in humans.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 26045773

Publisher access

Free full article in PubMed Central.

Extraction basis

Complete PMC article and PubMed metadata; full-text extraction checked 9 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.